Form 4: Marpai Director Robert Pons Boosts Equity Holdings
Insider Transaction Report
Marpai, Inc. Director Robert M. Pons reported the acquisition of 225,000 shares of Class A Common Stock through RSU grants, increasing his direct beneficial ownership to 309,200 shares.
Summary
- Robert M. Pons, a Director of Marpai, Inc. (MRAI), acquired a total of 225,000 shares of Class A Common Stock through Restricted Stock Unit (RSU) grants on October 20, 2025.
- The transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer, intended to satisfy Rule 10b5-1(c).
- The acquisitions were made at a price of $0 per share, indicating they are compensation-related grants.
- Following these transactions, Robert M. Pons directly beneficially owns 309,200 shares of Class A Common Stock.
- The grants include 50,000 RSUs deemed fully vested on the issuance date.
- An additional 75,000 RSUs will vest over nine months, with 25,000 RSUs vesting on the three, six, and nine-month anniversaries of the grant date.
- A further 100,000 RSUs were granted, with 50,000 deemed fully vested on the issuance date and the remaining 50,000 vesting upon the Company's uplisting to Nasdaq.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive. While RSU grants are compensation and not direct cash purchases, they increase insider ownership and align the director's interests with shareholders. The vesting condition tied to a Nasdaq uplisting also suggests a positive strategic direction for the company.
Positives
- Increased insider ownership by a Director, which can signal confidence in the company's future prospects and aligns management interests with shareholders.
- The RSU grants are part of a structured compensation plan, indicating ongoing commitment and retention of key management.
Negatives
- The acquisitions were RSU grants at a $0 price, not open market purchases, which typically carry a stronger signal of insider conviction as they involve personal capital at risk.
Future Outlook
A portion of the RSU grants (50,000 shares) is contingent upon the Company's uplisting to Nasdaq, indicating a strategic goal for Marpai, Inc.
Industry Context
Insider transactions, particularly RSU grants, are common forms of executive compensation in publicly traded companies. They are designed to align the interests of management with those of shareholders by providing equity-based incentives. The mention of a Nasdaq uplisting suggests the company is pursuing growth and increased market visibility, a common strategy for smaller public companies.
Related Party Transactions
- The RSU grants are a form of compensation from Marpai, Inc. to its Director, Robert M. Pons, which can be considered a related party transaction in the context of executive compensation.
Stakeholder Impact
- Shareholders: Increased alignment of a director's interests with shareholders due to higher equity ownership.
- Employees: The company's pursuit of a Nasdaq uplisting could indicate growth opportunities and increased visibility, potentially benefiting employees.
Next Steps
- Vesting of 75,000 RSUs over the next nine months (25,000 shares at 3, 6, and 9-month anniversaries from October 20, 2025).
- Potential uplisting of Marpai, Inc. to Nasdaq, which would trigger the vesting of an additional 50,000 RSUs for Robert Pons.
Key Dates
| Date | Description |
|---|---|
| 10/20/2025 | Date of earliest transaction for the acquisition of Class A Common Stock through RSU grants. |
| 10/22/2025 | Date the Form 4 was signed and filed by Robert Pons. |
Keywords
Marpai Inc, MRAI, Robert Pons, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Grants, Beneficial Ownership, Corporate Governance, Nasdaq Uplisting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.